Uploaded July 2025 | Updated September 2026, 2 weeks ago
NEW CannMed Coffee Talk, we discuss The Chemical Transformation of Cannabinoids! #shorts #cannabiseducation #cannabisdaily
Dr. Mark Scialdone is a recognized expert in the field of organic chemistry, specializing in natural product chemistry, including plant oil extraction, analysis, and chemical modification. He is an inventor of 37 issued US patents and has authored 17 peer-reviewed publications, during more than two decades of fundamental and product development research. He has given numerous invited lectures at more than 40 different academic institutions and international symposia.
At CannMed 25, Mark participated in the Hemp-Derived Cannabinoids panel, which explored the rapid rise of products containing chemically transformed cannabinoids to exploit the 2018 Farm Bill loophole. He also presented a poster that explained the process for chemically converting cannabinoids in more detail.
During the conversation, we discussed:
⦿ Why producers and manufacturers would want to convert one cannabinoid into another
⦿ Common methods for cannabinoid conversion
⦿ Safety risks associated with chemical cannabinoid conversion
⦿ The legality of these compounds
⦿ How these compounds and these products are affecting the legal cannabis market
⦿ The therapeutic potential of novel, chemically-converted cannabinoids
⦿ And more!
Thanks to This Episode’s Sponsor: @CannabisTechToday
NEW CannMed Coffee Talk, we discuss The Chemical Transformation of Cannabinoids! #shorts #cannabiseducation #cannabisdaily
Dr. Mark Scialdone is a recognized expert in the field of organic chemistry, specializing in natural product chemistry, including plant oil extraction, analysis, and chemical modification. He is an inventor of 37 issued US patents and has authored 17 peer-reviewed publications, during more than two decades of fundamental and product development research. He has given numerous invited lectures at more than 40 different academic institutions and international symposia.
At CannMed 25, Mark participated in the Hemp-Derived Cannabinoids panel, which explored the rapid rise of products containing chemically transformed cannabinoids to exploit the 2018 Farm Bill loophole. He also presented a poster that explained the process for chemically converting cannabinoids in more detail.
During the conversation, we discussed:
⦿ Why producers and manufacturers would want to convert one cannabinoid into another
⦿ Common methods for cannabinoid conversion
⦿ Safety risks associated with chemical cannabinoid conversion
⦿ The legality of these compounds
⦿ How these compounds and these products are affecting the legal cannabis market
⦿ The therapeutic potential of novel, chemically-converted cannabinoids
⦿ And more!
Thanks to This Episode’s Sponsor: @CannabisTechToday
